Ovid Therapeutics Inc. (OVID): $3.73

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OVID to Watchlist
Sign Up

Industry: Biotech


Ranked

of 499

in industry

Ovid Therapeutics Inc (OVID) Price Targets From Analysts

Use the tables below to see what analysts covering Ovid Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $7 $4 $4.88 $3.76 29.79%

The Trend in the Analyst Price Target


OVID's average price target has moved down $9.95 over the prior 43 weeks.

Over the past 15 months, OVID's average upside potential has been 86.74%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 4 7 4 4.88 3.740 30.48%
2021-07-17 4 7 4 4.88 3.700 31.89%
2021-07-10 4 7 4 4.88 3.940 23.86%
2021-07-03 4 7 4 4.88 4.040 20.79%
2021-06-24 4 7 4 4.88 4.290 13.75%
2021-06-13 4 8 4 5.88 4.490 30.96%
2021-06-05 4 8 4 5.88 4.380 34.25%
2021-05-03 4 8 4 6.00 3.730 60.86%
2021-04-25 4 8 4 6.00 3.670 63.49%
2021-04-17 4 8 5 6.25 3.780 65.34%
2021-04-10 4 8 5 6.25 3.690 69.38%
2021-04-03 4 8 5 6.25 4.070 53.56%
2021-03-20 4 8 5 6.25 4.470 39.82%
2021-03-02 4 8 4 6.00 2.960 102.7%
2021-02-27 4 8 4 6.00 2.950 103.39%
2021-02-20 4 8 4 6.00 3.470 72.91%
2021-02-13 4 8 4 6.00 3.420 75.44%
2021-02-06 4 8 4 6.00 3.190 88.09%
2021-01-30 4 8 4 6.00 2.810 113.52%
2021-01-23 4 8 4 6.00 2.710 121.4%
2021-01-07 4 8 4 6.00 2.500 140%
2020-12-30 4 8 4 6.00 2.380 152.1%
2020-12-26 4 8 4 6.00 2.610 129.89%
2020-12-19 4 8 4 6.00 2.650 126.42%
2020-12-10 4 8 4 6.00 2.620 129.01%
2020-12-07 4 8 4 6.00 2.580 132.56%
2020-11-13 6 21 10 14.67 6.040 142.88%
2020-09-29 6 21 10 14.83 5.980 147.99%
2020-09-23 6 21 10 14.19 5.800 144.66%
2020-08-25 6 21 10 14.19 6.335 123.99%
2020-08-10 6 21 9 13.52 7.140 89.36%
2020-07-31 6 21 9 12.96 6.450 100.93%
2020-07-21 5 21 9 13.60 NA NA%
2020-07-13 5 21 9 13.60 NA NA%
2020-07-05 5 20 8 13.00 NA NA%
2020-06-17 6 20 8 12.43 NA NA%
2020-05-14 6 20 7 11.43 NA NA%

OVID Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.64 2 1 4 0 0 7

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Ovid Therapeutics Inc's average analyst price target is greater than 7.68% of all US stocks.
  • The variance in analysts' estimates of OVID is less than 15.24% of stocks in the small market cap category.
  • The upside potential (average analyst target price relative to current price) of OVID is higher than 18.97% of Pharmaceutical Products stocks.
  • OVID has a greater number of analysts covering the stock than 33.95% of Pharmaceutical Products stocks.

Stocks similar to Ovid Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RUBY, KIN and OGN.

Is OVID a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6253 seconds.